Patents by Inventor Deanna J. Nelson

Deanna J. Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Magnesium biotinate compositions and methods of use
    Patent number: 11938117
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: March 26, 2024
    Assignee: Nutrition21, LLC
    Inventors: Deanna J. Nelson, James R. Komorowski
  • Magnesium biotinate compositions and methods of use
    Patent number: 11931342
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: March 19, 2024
    Assignee: Nutrition21, LLC
    Inventors: Deanna J. Nelson, James R. Komorowski
  • CALCIUM SUCCINATE MONOHYDRATE FORMULATION
    Publication number: 20240050388
    Abstract: This invention relates to a ready to use, orally administered formulation containing a therapeutically effective amount of calcium as calcium succinate monohydrate with unexpected palatability, chemical and physical stability, and availability for phosphate binding in the gastrointestinal tract of a subject.
    Type: Application
    Filed: August 14, 2023
    Publication date: February 15, 2024
    Inventor: Deanna J. Nelson
  • COMBINATIONS OF CARNOSINE AND ZINC FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS
    Publication number: 20230301959
    Abstract: The present invention relates to the treatment of viral infection, and in particular to the use of an amount of a chelate of zinc and L-camosineeffective to treat or to prevent infections associated with viruses in said human cells.
    Type: Application
    Filed: June 23, 2021
    Publication date: September 28, 2023
    Inventor: Deanna J. Nelson
  • LIQUID CONCENTRATES OF CALCIUM AND MAGNESIUM
    Publication number: 20220175828
    Abstract: The present invention relates to a liquid concentrate of calcium propionate and a magnesium salt, optionally with sweetener, taste-masking agent, flavoring, and thickening agent. Also provided is a method for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of a subject by administering to the subject a liquid concentrate of at least calcium salt and magnesium salt.
    Type: Application
    Filed: April 10, 2020
    Publication date: June 9, 2022
    Inventor: Deanna J. Nelson
  • Method and Composition for Enhancing the Quality and Benefits of Sleep
    Publication number: 20210308081
    Abstract: Compounds, compositions and methods of making and using for enhancing the quality and benefit of sleep and/or wakefulness in a subject in need thereof.
    Type: Application
    Filed: April 5, 2021
    Publication date: October 7, 2021
    Inventors: Deanna J. Nelson, James R. Komorowski
  • Method and Composition for Enhancing the Quality and Benefits of Sleep
    Publication number: 20210308177
    Abstract: Compounds, compositions and methods of making and using for enhancing the quality and benefit of sleep and/or wakefulness in a subject in need thereof.
    Type: Application
    Filed: April 29, 2021
    Publication date: October 7, 2021
    Inventors: Deanna J. Nelson, James R. Komorowski
  • Pharmaceutical quality strontium L-lactate
    Patent number: 11026906
    Abstract: The present application relates to strontium L-lactate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable strontium to mammals and treating or preventing symptoms of bone and/or cartilage disorders.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: June 8, 2021
    Inventor: Deanna J. Nelson
  • MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20210100776
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Application
    Filed: April 22, 2020
    Publication date: April 8, 2021
    Inventors: Deanna J. Nelson, James R. Komorowski
  • PHARMACEUTICAL QUALITY STRONTIUM L-LACTATE
    Publication number: 20200016101
    Abstract: The present application relates to strontium L-lactate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable strontium to mammals and treating or preventing symptoms of bone and/or cartilage disorders.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 16, 2020
    Inventor: Deanna J. Nelson
  • Pharmaceutical quality strontium L-lactate
    Patent number: 10463636
    Abstract: The present application relates to strontium L-lactate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable strontium to mammals and treating or preventing symptoms of bone and/or cartilage disorders.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: November 5, 2019
    Inventor: Deanna J. Nelson
  • MAGNESIUM PICOLINATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20180098976
    Abstract: The present application relates to magnesium picolinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable magnesium to mammals and treating or preventing symptoms of magnesium deficiency.
    Type: Application
    Filed: October 11, 2017
    Publication date: April 12, 2018
    Inventors: Deanna J. Nelson, James R. Komorowski
  • PHARMACEUTICAL QUALITY STRONTIUM L-LACTATE
    Publication number: 20180092869
    Abstract: The present application relates to strontium L-lactate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable strontium to mammals and treating or preventing symptoms of bone and/or cartilage disorders.
    Type: Application
    Filed: September 26, 2017
    Publication date: April 5, 2018
    Inventor: Deanna J. Nelson
  • MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20180071264
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Application
    Filed: August 31, 2017
    Publication date: March 15, 2018
    Inventors: Deanna J. Nelson, James R. Komorowski
  • Phosphorus binder composition for treatment of hyperphosphatemia
    Patent number: 8759398
    Abstract: The present invention relates to oral pharmaceutical products which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: June 24, 2014
    Assignee: Biolink Life Sciences, Inc.
    Inventor: Deanna J. Nelson
  • METHOD AND COMPOSITIONS FOR ENHANCING THE SAFETY OF ORALLY ADMINISTERED MAGNESIUM ALPHA-LIPOATE
    Publication number: 20130296390
    Abstract: The present invention relates to oral nutritional and therapeutic products which are useful for enhancing the safety of administering and reducing the adverse effects caused by magnesium alpha-lipoate to a warm-blooded mammal, comprising administering magnesium alpha-lipoate with D-biotin.
    Type: Application
    Filed: April 30, 2013
    Publication date: November 7, 2013
    Applicant: BioLink Life Sciences, Inc.
    Inventor: Deanna J. Nelson
  • PHOSPHORUS BINDER COMPOSITION FOR TREATMENT OF HYPERPHOSPHATEMIA
    Publication number: 20130296433
    Abstract: The present invention relates to oral pharmaceutical products which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy.
    Type: Application
    Filed: July 3, 2013
    Publication date: November 7, 2013
    Inventor: Deanna J. Nelson
  • STABLE, WATER-INSOLUBLE R-(+)-ALPHA-LIPOIC ACID SALT USEFUL FOR THE TREATMENT OF DIABETES MELLITUS AND ITS CO-MORBIDITIES
    Publication number: 20120283320
    Abstract: The present invention relates to oral nutritional and therapeutic products which are useful for preventing or treating compensated and decompensated insulin resistance and associated diseases and sequelae, or diabetes mellitus and its sequelae, complications, and co-morbidities, comprising magnesium R-(+)-alpha-lipoate.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 8, 2012
    Applicant: BIOLINK LIFE SCIENCES, INC.
    Inventor: Deanna J. Nelson
  • Stable, water-insoluble R-(+)-?-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities
    Patent number: 8222432
    Abstract: The present invention relates to oral nutritional and therapeutic products which are useful for preventing or treating compensated and decompensated insulin resistance and associated diseases and sequelae, or diabetes mellitus and its sequelae, complications, and co-morbidities, comprising magnesium R-(+)-alpha-lipoate.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: July 17, 2012
    Assignee: BioLink Life Sciences, Inc.
    Inventor: Deanna J. Nelson
  • PHOSPHORUS BINDER COMPOSITION FOR TREATMENT OF HYPERPHOSPHATEMIA
    Publication number: 20110269837
    Abstract: The present invention relates to oral pharmaceutical products which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 3, 2011
    Applicant: BIOLINK LIFE SCIENCES, INC.
    Inventor: Deanna J. Nelson